Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|August 7, 2016
Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In VivoBarbara A Helfrich, Jihye Kim, Dexiang Gao, et al.
Operative Dentistry|August 1, 2008
Comparison of traditional and low sensitivity whitenersWilliam D Browning, Daniel C Chan, Michael L Myers, et al.
Canadian Journal of Physiology and Pharmacology|May 25, 2002
Bradykinin-related compounds as new drugs for cancer and inflammationJohn M Stewart, Lajos Gera, Daniel C Chan, et al.
Peptides|May 10, 2005
Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonistsJohn M Stewart, Lajos Gera, Daniel C Chan, et al.
Disease Models & Mechanisms|February 21, 2012
A translation inhibitor identified in a Drosophila screen enhances the effect of ionizing radiation and taxol in mammalian models of cancerMara Gladstone, Barbara Frederick, Di Zheng, et al.
Translational Oncology|May 5, 2009
Loss of NADPH quinone oxidoreductase in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant 2alpha in hormone-stimulated noble rats: potential role in prostatic intraepithelial neoplasia developmentRita Ghosh, John Schoolfield, I-Tien Yeh, et al.
International Immunopharmacology|December 20, 2002
Bradykinin antagonists as new drugs for prostate cancerJohn M Stewart, Daniel C Chan, Vitalija Simkeviciene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancerDavid Raben, Barb Helfrich, Daniel C Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agentsDaniel C Chan, Lajos Gera, John M Stewart, et al.
Seminars in Oncology|March 15, 2002
Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancerPaul A Bunn, Daniel C Chan, Keith Earle, et al.
Pageof 3